168 related articles for article (PubMed ID: 34094676)
21. Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.
D'Angelo D; Esposito F; Fusco A
Front Med (Lausanne); 2015; 2():39. PubMed ID: 26137461
[TBL] [Abstract][Full Text] [Related]
22. Regulation of T Cell Differentiation and Function by EZH2.
Karantanos T; Chistofides A; Barhdan K; Li L; Boussiotis VA
Front Immunol; 2016; 7():172. PubMed ID: 27199994
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
25. HMGA1-pseudogene expression is induced in human pituitary tumors.
Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
[TBL] [Abstract][Full Text] [Related]
26. HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion.
Ros G; Pegoraro S; De Angelis P; Sgarra R; Zucchelli S; Gustincich S; Manfioletti G
Front Oncol; 2019; 9():1526. PubMed ID: 32010621
[No Abstract] [Full Text] [Related]
27. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
[TBL] [Abstract][Full Text] [Related]
28. Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
Joetzke AE; Sterenczak KA; Eberle N; Wagner S; Soller JT; Nolte I; Bullerdiek J; Murua Escobar H; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):87-95. PubMed ID: 20579321
[TBL] [Abstract][Full Text] [Related]
29. HMGA1 and HMGA2 protein expression in mouse spermatogenesis.
Chieffi P; Battista S; Barchi M; Di Agostino S; Pierantoni GM; Fedele M; Chiariotti L; Tramontano D; Fusco A
Oncogene; 2002 May; 21(22):3644-50. PubMed ID: 12032866
[TBL] [Abstract][Full Text] [Related]
30. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.
Lu H; Li G; Zhou C; Jin W; Qian X; Wang Z; Pan H; Jin H; Wang X
Am J Cancer Res; 2016; 6(12):2737-2754. PubMed ID: 28042497
[TBL] [Abstract][Full Text] [Related]
31. Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.
Honma D; Kanno O; Watanabe J; Kinoshita J; Hirasawa M; Nosaka E; Shiroishi M; Takizawa T; Yasumatsu I; Horiuchi T; Nakao A; Suzuki K; Yamasaki T; Nakajima K; Hayakawa M; Yamazaki T; Yadav AS; Adachi N
Cancer Sci; 2017 Oct; 108(10):2069-2078. PubMed ID: 28741798
[TBL] [Abstract][Full Text] [Related]
32. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
Yan J; Ng SB; Tay JL; Lin B; Koh TL; Tan J; Selvarajan V; Liu SC; Bi C; Wang S; Choo SN; Shimizu N; Huang G; Yu Q; Chng WJ
Blood; 2013 May; 121(22):4512-20. PubMed ID: 23529930
[TBL] [Abstract][Full Text] [Related]
33. HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma.
Palumbo A; Da Costa NM; Esposito F; De Martino M; D'Angelo D; de Sousa VP; Martins I; Nasciutti LE; Fusco A; Ribeiro Pinto LF
Oncotarget; 2016 May; 7(18):25872-84. PubMed ID: 27027341
[TBL] [Abstract][Full Text] [Related]
34. EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys
Huang JP; Ling K
Oncol Lett; 2017 Nov; 14(5):5735-5742. PubMed ID: 29113202
[TBL] [Abstract][Full Text] [Related]
35. EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma.
Yan J; Li B; Lin B; Lee PT; Chung TH; Tan J; Bi C; Lee XT; Selvarajan V; Ng SB; Yang H; Yu Q; Chng WJ
Blood; 2016 Aug; 128(7):948-58. PubMed ID: 27297789
[TBL] [Abstract][Full Text] [Related]
36. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas.
Pierantoni GM; Battista S; Pentimalli F; Fedele M; Visone R; Federico A; Santoro M; Viglietto G; Fusco A
Carcinogenesis; 2003 Dec; 24(12):1861-9. PubMed ID: 12970064
[TBL] [Abstract][Full Text] [Related]
37. HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.
Andreozzi M; Quintavalle C; Benz D; Quagliata L; Matter M; Calabrese D; Tosti N; Ruiz C; Trapani F; Tornillo L; Fusco A; Heim MH; Ng CK; Pallante P; Terracciano LM; Piscuoglio S
Neoplasia; 2016 Dec; 18(12):724-731. PubMed ID: 27855356
[TBL] [Abstract][Full Text] [Related]
38. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation.
Song X; Zhang L; Gao T; Ye T; Zhu Y; Lei Q; Feng Q; He B; Deng H; Yu L
Biomed Pharmacother; 2016 Jul; 81():288-294. PubMed ID: 27261606
[TBL] [Abstract][Full Text] [Related]
40. Roles of the EZH2 histone methyltransferase in cancer epigenetics.
Simon JA; Lange CA
Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]